Breaking News Instant updates and real-time market news.

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

, LZAGY

Lonza

$0.00

(0.00%)

18:18
10/16/19
10/16
18:18
10/16/19
18:18

Mesoblast, Lonza enter into manufacture agreement of remestemcel-L in U.S.

Mesoblast (MESO) and Lonza (LZAGY) announced that they have entered into an agreement for commercial manufacture of Mesoblast's lead allogeneic cell therapy product candidate, remestemcel-L for pediatric steroid-refractory acute graft versus host disease. This agreement will facilitate inventory build ahead of the planned United States market launch of remestemcel-L and commercial supply to meet Mesoblast's long-term market projections. Mesoblast expects to complete filing of the rolling Biologics License Application submission to the FDA by the end of this year. On acceptance of the filing, the product candidate is eligible for FDA priority review under its existing Fast Track designation, providing for an expedited review period. If approved, the US launch of remestemcel-L is expected to occur next year.

MESO

Mesoblast

$6.04

-0.03 (-0.49%)

LZAGY

Lonza

$0.00

(0.00%)

MESO Mesoblast
$6.04

-0.03 (-0.49%)

01/31/19
HCWC
01/31/19
INITIATION
Target $6.5
HCWC
Buy
Mesoblast assumed with a Buy at H.C. Wainwright
H.C. Wainwright analyst Swayampakula Ramakanth assumed coverage of Mesoblast with a Buy rating and $6.50 price target. The company's proprietary platform has been validated by two commercial cellular therapy products, TEMCELL and Alofisel, which were approved in Japan in 2015 for the treatment of acute Graft Versus Host Disease, and in Europe in 2018 for the treatment of perianal fistula, Ramakanth tells investors in a research note. Further, he calls Mesoblast's product pipeline "mature" with seven product candidates targeting ten indications.
09/10/19
CANT
09/10/19
NO CHANGE
Target $23
CANT
Overweight
Mesoblast partnership deal with Grunenthal a positive, says Cantor Fitzgerald
Cantor Fitzgerald analyst Elemer Piros reiterates an Overweight rating on Mesoblast with a $23 price target after the company announced a strategic partnership with Grunenthal related to MPC-06-ID for the treatment of chronic low back pain due to degenerative disc disease. Having the support to run a Phase 3 confirmatory study in Europe as well as receiving an additional source of income are positive for Mesoblast, as the company's pipeline moves toward late-stage development and commercialization, Piros tells investors in a research note. Further, with all the recent concerns about opioid use, he believes that if the Phase 3 trials read out positively, MPC-06-ID "represents a safer and more-compelling treatment option" for lower back pain. The analyst also thinks Grunewald could be a strong partner for Mesoblast.
LZAGY Lonza
$0.00

(0.00%)

01/31/19
BOFA
01/31/19
DOWNGRADE
BOFA
Neutral
Lonza downgraded to Neutral from Buy at BofA/Merrill

TODAY'S FREE FLY STORIES

13:55
11/14/19
11/14
13:55
11/14/19
13:55
Conference/Events
MoffettNathanson to hold an analyst/industry conference call »

Michael Nathanson (Media…

BA

Boeing

$367.78

5.36 (1.48%)

13:55
11/14/19
11/14
13:55
11/14/19
13:55
Conference/Events
Cowen aerospace & defense analysts to hold analyst/industry conference call »

Aerospace & Defense…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

NEWR

New Relic

$65.17

0.62 (0.96%)

, W

Wayfair

$82.03

-1.685 (-2.01%)

13:46
11/14/19
11/14
13:46
11/14/19
13:46
Hot Stocks
Tiger Global adds New Relic, Wayfair and Beyond Meat during Q3 »

Chase Coleman's…

NEWR

New Relic

$65.17

0.62 (0.96%)

W

Wayfair

$82.03

-1.685 (-2.01%)

PLAN

Anaplan

$47.82

-1.28 (-2.61%)

WORK

Slack Technologies

$21.21

-0.09 (-0.42%)

BYND

Beyond Meat

$80.80

1.82 (2.30%)

PVTL

Pivotal Software

$15.00

-0.01 (-0.07%)

LK

Luckin Coffee

$21.54

0.105 (0.49%)

BABA

Alibaba

$181.75

-0.73 (-0.40%)

FB

Facebook

$192.10

-1.1 (-0.57%)

CVNA

Carvana

$77.87

2.79 (3.72%)

RUN

Sunrun

$14.35

0.575 (4.17%)

RNG

RingCentral

$167.60

0.09 (0.05%)

FCAU

Fiat Chrysler

$16.00

0.1 (0.63%)

SVMK

SurveyMonkey

$16.69

0.29 (1.77%)

SPOT

Spotify

$148.49

1.72 (1.17%)

STNE

StoneCo

$36.40

0.43 (1.20%)

RDFN

Redfin

$20.42

0.36 (1.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 04

    Dec

  • 04

    Dec

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 19

    Dec

  • 13

    Nov

LIQT

LiqTech

$4.71

-2.4 (-33.76%)

13:44
11/14/19
11/14
13:44
11/14/19
13:44
Recommendations
LiqTech analyst commentary  »

LiqTech post-earnings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

WB

Weibo

$44.06

-8.75 (-16.57%)

13:35
11/14/19
11/14
13:35
11/14/19
13:35
Downgrade
Weibo rating change  »

Weibo downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

DF

Dean Foods

$0.00

(0.00%)

13:32
11/14/19
11/14
13:32
11/14/19
13:32
Hot Stocks
Dean Foods receives court approval of 'first day' motions to support operations »

Dean Foods announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RETA

Reata Pharmaceuticals

$196.01

9.01 (4.82%)

13:28
11/14/19
11/14
13:28
11/14/19
13:28
Recommendations
Reata Pharmaceuticals analyst commentary  »

Reata Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

13:28
11/14/19
11/14
13:28
11/14/19
13:28
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

WDC

Western Digital

$50.31

-0.75 (-1.47%)

13:25
11/14/19
11/14
13:25
11/14/19
13:25
Options
Western Digital call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

  • 09

    Dec

13:23
11/14/19
11/14
13:23
11/14/19
13:23
Hot Stocks
Breaking Hot Stocks news story  »

TKK Symphony Acquisition…

GOOG

Alphabet

$1,309.36

11.75 (0.91%)

, GOOGL

Alphabet Class A

$1,308.00

12 (0.93%)

13:20
11/14/19
11/14
13:20
11/14/19
13:20
Hot Stocks
Google to no longer include contextual content categories in ad bid requests »

Alphabet's Google…

GOOG

Alphabet

$1,309.36

11.75 (0.91%)

GOOGL

Alphabet Class A

$1,308.00

12 (0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/14/19
11/14
13:17
11/14/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/14/19
11/14
13:16
11/14/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
11/14/19
11/14
13:15
11/14/19
13:15
General news
NY Fed's Williams repeated the new mantra that the economy and policy are "in a good place," »

NY Fed's Williams…

RBBN

Ribbon Communications

$3.05

-1 (-24.69%)

13:13
11/14/19
11/14
13:13
11/14/19
13:13
Downgrade
Ribbon Communications rating change  »

Ribbon Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$33.13

-0.23 (-0.69%)

, WVE

Wave Life Sciences

$27.77

-0.2 (-0.72%)

13:09
11/14/19
11/14
13:09
11/14/19
13:09
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

JD

JD.com

$33.13

-0.23 (-0.69%)

WVE

Wave Life Sciences

$27.77

-0.2 (-0.72%)

RYTM

Rhythm Pharmaceuticals

$21.49

0.35 (1.66%)

JCP

J.C. Penney

$1.09

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

  • 09

    Dec

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

, AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

13:09
11/14/19
11/14
13:09
11/14/19
13:09
Earnings
Notable companies reporting after market close »

Notable companies…

NVDA

Nvidia

$207.78

-0.77 (-0.37%)

AMAT

Applied Materials

$56.90

-0.23 (-0.40%)

WPM

Wheaton Precious Metals

$26.64

0.05 (0.19%)

DLB

Dolby

$65.71

0.01 (0.02%)

HP

Helmerich & Payne

$39.57

0.31 (0.79%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 15

    Nov

  • 20

    Nov

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 13

    Dec

  • 06

    Jan

13:05
11/14/19
11/14
13:05
11/14/19
13:05
General news
Fed dove Bullard said policy is "considerably" more accommodative »

Fed dove Bullard said…

MDU

MDU Resources

$29.13

0.02 (0.07%)

13:02
11/14/19
11/14
13:02
11/14/19
13:02
Hot Stocks
MDU Resources increases quarterly dividend »

The MDU Resources Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SSTI

ShotSpotter

$22.52

0.92 (4.26%)

13:01
11/14/19
11/14
13:01
11/14/19
13:01
Recommendations
ShotSpotter analyst commentary  »

ShotSpotter price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$208.11

-0.44 (-0.21%)

, AMZN

Amazon.com

$1,754.91

1.07 (0.06%)

13:00
11/14/19
11/14
13:00
11/14/19
13:00
On The Fly
Fly Intel: What to watch in Nvidia earnings report »

Nvidia (NVDA) is…

NVDA

Nvidia

$208.11

-0.44 (-0.21%)

AMZN

Amazon.com

$1,754.91

1.07 (0.06%)

INTC

Intel

$57.97

0.05 (0.09%)

VMW

VMware

$165.99

0.25 (0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

  • 20

    Nov

  • 26

    Nov

  • 09

    Dec

  • 09

    Dec

  • 06

    Jan

  • 23

    Jan

BABA

Alibaba

$182.49

0.01 (0.01%)

13:00
11/14/19
11/14
13:00
11/14/19
13:00
Options
$5.5M buy in Alibaba calls possibly closes »

$5.5M buy in Alibaba…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

AMZN

Amazon.com

$1,754.00

0.16 (0.01%)

, GOOG

Alphabet

$1,306.86

9.25 (0.71%)

12:55
11/14/19
11/14
12:55
11/14/19
12:55
Conference/Events
House Committee on Small Business to hold a hearing »

The Committee holds a…

AMZN

Amazon.com

$1,754.00

0.16 (0.01%)

GOOG

Alphabet

$1,306.86

9.25 (0.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

TSLA

Tesla

$351.71

5.71 (1.65%)

12:49
11/14/19
11/14
12:49
11/14/19
12:49
Periodicals
Tesla's Model 3 and Model S regain Consumer Reports recommendation »

Two of Tesla's three…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALIM

Alimera Sciences

$0.28

0.0355 (14.75%)

12:46
11/14/19
11/14
12:46
11/14/19
12:46
Hot Stocks
Alimera says stock to begin trading on post-reverse split basis on Nov. 15 »

Alimera Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.